Iain Wilkie
Stock Analyst at Morgans
(0.11)
# 4,637
Out of 4,698 analysts
154
Total ratings
29.1%
Success rate
-12.5%
Average return
Main Sectors:
Stocks Rated by Iain Wilkie
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: EIQ Echo IQ Limited | Maintained: Buy | $1.85 | $1.28 | +44.53% | 3 | Sep 2, 2026 | |
| ASX: CUV Clinuvel Pharmaceuticals Limited | Downgraded: Hold | $13.00 → $10.00 | $8.15 | +22.70% | 7 | Aug 31, 2026 | |
| ASX: SOM SomnoMed Limited | Maintained: Buy | $0.75 → $0.76 | $0.35 | +120.29% | 21 | Aug 31, 2026 | |
| ASX: M7T Mach7 Technologies Limited | Maintained: Buy | $0.44 → $0.48 | $0.28 | +71.43% | 10 | Aug 31, 2026 | |
| ASX: IME ImExHS Limited | Downgraded: Hold | $0.50 → $0.37 | $0.36 | +4.23% | 14 | Aug 31, 2026 | |
| ASX: PME Pro Medicus Limited | Maintained: Buy | $230.00 | $173.95 | +32.22% | 29 | Aug 19, 2026 | |
| ASX: NUZ Neurizon Therapeutics Limited | Maintained: Buy | $0.20 | $0.06 | +257.14% | 10 | Jul 19, 2026 | |
| ASX: MAP Microba Life Sciences Limited | Maintained: Buy | $0.12 | $0.06 | +118.18% | 10 | Jul 16, 2026 | |
| ASX: NAN Nanosonics Limited | Maintained: Buy | $5.00 → $4.00 | $2.76 | +44.93% | 7 | Feb 25, 2026 | |
| ASX: PIQ Proteomics International Laboratories Ltd | Downgraded: Sell | $0.43 | $0.15 | +186.67% | 7 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.58 → $0.24 | $0.01 | n/a | 8 | Sep 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.22 → $0.29 | $0.03 | n/a | 4 | Sep 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1.28 → $0.78 | $0.27 | n/a | 14 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.43 | $0.09 | n/a | 3 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.31 → $1.24 | $0.30 | n/a | 4 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.89 → $1.64 | $0.02 | n/a | 3 | Feb 16, 2022 |
Echo IQ Limited
Sep 2, 2026
Maintained: Buy
Price Target: $1.85
Current: $1.28
Upside: +44.53%
Clinuvel Pharmaceuticals Limited
Aug 31, 2026
Downgraded: Hold
Price Target: $13.00 → $10.00
Current: $8.15
Upside: +22.70%
SomnoMed Limited
Aug 31, 2026
Maintained: Buy
Price Target: $0.75 → $0.76
Current: $0.35
Upside: +120.29%
Mach7 Technologies Limited
Aug 31, 2026
Maintained: Buy
Price Target: $0.44 → $0.48
Current: $0.28
Upside: +71.43%
ImExHS Limited
Aug 31, 2026
Downgraded: Hold
Price Target: $0.50 → $0.37
Current: $0.36
Upside: +4.23%
Pro Medicus Limited
Aug 19, 2026
Maintained: Buy
Price Target: $230.00
Current: $173.95
Upside: +32.22%
Neurizon Therapeutics Limited
Jul 19, 2026
Maintained: Buy
Price Target: $0.20
Current: $0.06
Upside: +257.14%
Microba Life Sciences Limited
Jul 16, 2026
Maintained: Buy
Price Target: $0.12
Current: $0.06
Upside: +118.18%
Nanosonics Limited
Feb 25, 2026
Maintained: Buy
Price Target: $5.00 → $4.00
Current: $2.76
Upside: +44.93%
Proteomics International Laboratories Ltd
Feb 2, 2026
Downgraded: Sell
Price Target: $0.43
Current: $0.15
Upside: +186.67%
Sep 2, 2024
Maintained: Buy
Price Target: $0.58 → $0.24
Current: $0.01
Upside: n/a
Sep 1, 2022
Maintained: Buy
Price Target: $0.22 → $0.29
Current: $0.03
Upside: n/a
Mar 9, 2022
Downgraded: Sell
Price Target: $1.28 → $0.78
Current: $0.27
Upside: n/a
Feb 28, 2022
Maintained: Buy
Price Target: $1.43
Current: $0.09
Upside: n/a
Feb 24, 2022
Maintained: Buy
Price Target: $1.31 → $1.24
Current: $0.30
Upside: n/a
Feb 16, 2022
Maintained: Buy
Price Target: $1.89 → $1.64
Current: $0.02
Upside: n/a